Governor DeWine Authorizes Emergency Classification of Xylazine as Schedule III Controlled Substance
March 30, 2023
March 30, 2023
COLUMBUS, Ohio, March 30 -- Gov. Mike DeWine, R-Ohio, issued the following news release on March 29, 2023:
Ohio Governor Mike DeWine signed an executive order directing the State of Ohio Board of Pharmacy to immediately classify xylazine as a Schedule III controlled substance, making Ohio one of the first states in the nation to schedule xylazine as a controlled substance drug.
Xylazine is a central nervous system depressant used in veterinary medicine as a sedative, an . . .
Ohio Governor Mike DeWine signed an executive order directing the State of Ohio Board of Pharmacy to immediately classify xylazine as a Schedule III controlled substance, making Ohio one of the first states in the nation to schedule xylazine as a controlled substance drug.
Xylazine is a central nervous system depressant used in veterinary medicine as a sedative, an . . .